Minomic International Ltd.

GLYTUZUMAB

Pharmaceutical and medical preparations for the diagnosis, treatment and prevention of cancer, oncological disorders, autoimmune diseases, and inflammatory diseases;

MICHECK

Diagnostic preparations for medical purposes, excluding preparations for use in blood glucose monitoring, insulin delivery systems, or diabetes care; diagnostic preparations for medical purposes in the nature of chemical preparations for diagnostic purposes, excluding preparations for use in blood glucose monitoring, insulin delivery systems, or diabetes care; chemicals and preparations for medical research and clinical testing of biological materials, namely, medical diagnostic reagents and assays for testing of body fluids, excluding chemicals and preparations for use in blood glucose monitoring, insulin delivery systems, or diabetes care; diagnostic testing materials for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, medical diagnostic test media in the form of polystyrene or magnetic beads for measuring the presence of certain cancers;Color is not claimed as a feature of the mark.;

MILTUXIMAB

pharmaceutical preparations for the diagnosis, treatment, or prevention of cancer, oncological disorders, auto-immune diseases, and inflammation diseases;